test

Liver Cancer Team

The Liver Cancer Team at Smilow Cancer Hospital offers an entire spectrum of therapies for liver cancer, also known as hepatobiliary carcinoma. The team includes a group of specialists - including hepatobiliary and transplant surgeons, hepatologists, diagnostic and interventional radiologists, pathologists, medical oncologists, and nurses - to reach a consensus on the best treatment for each patient. After treatment, the patient receives care to manage the underlying liver disease, preserve liver function, and survey for possible recurrence of the cancer.

A combination of interventional radiology and surgical techniques, including ablation therapy, liver resection, new chemotherapeutic options and liver transplantation, are now available; and in certain patients, these treatments can even cure the disease. For patients diagnosed with early disease, liver transplantation can provide the definitive cure for both the cancer and the advanced liver disease that frequently accompanies a diagnosis of cancer.

For patients who do not have advanced liver disease or for patients who cannot receive a liver transplant, surgical resection, ablative therapies such as transarterial chemoembolization or radiofrequency ablation (RFA) can provide excellent survival rates for the appropriate candidates.
Clinical Trials are available to patients with advanced disease, using new biological agents to target specific intracellular mechanisms of the cancerous cell.

Team Members:
 
Hepatology
·          Tamar Taddei, MD

Medical Oncology
·          Howard Hochster, MD
·          Stacey Stein, MD

Surgery
·          Charles Cha, MD
·          Ronald Salem, MD

Transplant
·          Sukru Emre, MD
·          Sanjay Kulkarni, MD

Diagnostic Radiology
·          Gary Israel, MD
·          Jeffrey Weinreb, MD

Interventional Radiology
·          Jeffrey Pollak, MD
·          Eric Reiner, MD

Pathology
·          Marie Robert, MD
·          Dhanpat Jain, MD
·          Kisha Mitchell, MD